Bruce Steel, CFA
Chief Executive Officer
Bruce is a co-founder, Director, and President and Chief Executive Officer of Equillium. He is also the founder and Managing Director of BioMed Ventures, the strategic investment arm of BioMed Realty, where he directed investments in over 30 biotechnology companies including Auspex, AnaptysBio, NeoTract, Promedior, and Receptos. Prior to co-founding Equillium, Bruce was co-founder and CEO of Rincon Pharmaceuticals, a genetic engineering biotechnology company, until its acquisition in 2008; previously he was Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences.
Bruce received his Bachelor of Arts degree from Dartmouth College and Master of Business Administration degree from the Marshall School of Business at the University of Southern California, and he holds the designation of Chartered Financial Analyst.